文献速递关节外科创伤骨科

全身炎症反应综合征与假体周围关节感染

Systemic Inflammatory Response Syndrome and Prosthetic Joint Infection.
PubMed 文献 · J Arthroplasty · 2023-07-31

该回顾性研究纳入2015年7月1日至2020年12月31日单机构655例髋或膝关节假体周围感染(PJI)患者,其中63例(9.6%)发生全身炎症反应综合征(SIRS)。PJI合并SIRS组ICU入住率、住院时长、2年再手术率和死亡率均高于单纯PJI组,且金黄色葡萄球菌在组织培养中更常见。

要点

  • PJI患者中SIRS发生率为9.6%(63/655)。
  • PJI+SIRS组ICU入住率27.0% vs 6.9%,住院时长7.7天 vs 5.6天。
  • PJI+SIRS组2年再手术率36.5% vs 22.3%,死亡率17.5% vs 8.8%。

核心结论

  • PJI患者中SIRS发生率为10%。
  • PJI合并SIRS与住院时间延长、ICU入住率增加以及2年再手术率和死亡率升高相关。
  • 识别特定合并症可对PJI患者发生SIRS的风险进行分层。

研究设计与样本

  • 回顾性识别2015年7月1日至2020年12月31日期间在1个机构诊断为髋或膝关节PJI的655例患者(321例男性,334例女性;382例全髋,273例全膝)。
  • 分为2组:有SIRS警报的PJI患者(PJI+SIRS)和无SIRS警报的PJI患者(PJI)。
  • 分析临床结局、合并症和手术室培养结果。

主要发现

  • 655例患者中63例(9.6%)发生PJI合并SIRS。
  • PJI+SIRS组ICU入住率为27.0%,PJI组为6.9%(P < .001)。
  • PJI+SIRS组住院时长为7.7天,PJI组为5.6天(P = .003)。
  • 2年时,PJI+SIRS组再手术率为36.5%,PJI组为22.3%(P = .01)。
  • 2年时,PJI+SIRS组死亡率为17.5%,PJI组为8.8%(P = .03)。

关键数值与推荐

  • 风险因素包括缺乏性贫血(P = .001)、失血性贫血(P = .013)、无并发症糖尿病(P = .006)、伴并发症糖尿病(P = .001)、电解质紊乱(P < .00001)、神经系统疾病(P = .0001)、瘫痪(P = .026)、肾衰竭(P = .005)和消化性溃疡病(P = .004)。
  • PJI+SIRS组组织培养中金黄色葡萄球菌更常见(P = .002)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The development of systemic inflammatory response syndrome (SIRS) criteria leads to increased mortality. Little is known about development of SIRS in patients who have prosthetic joint infection (PJI). We aimed to determine the incidence, risk factors, clinical outcomes, and causative organisms in patients who develop SIRS with PJI. METHODS: We retrospectively identified 655 patients (321 men, 334 women; 382 total hip, 273 total knee) who have hip or knee PJI at 1 institution between July 1, 2015 and December 31, 2020. We formed 2 groups: patients who have SIRS alert (PJI + SIRS) and patients who do not have SIRS alert (PJI). We analyzed clinical outcomes, comorbidities, and operating room culture results. RESULTS: Of 655 patients, 63 developed SIRS with PJI (9.6%). Intensive care unit (ICU) admission rates (27.0 versus. 6.9%, P < .001) and length of stay (7.7 versus. 5.6 days, P = .003) were greater in PJI + SIRS. At 2 years, reoperation (36.5 versus. 22.3%, P = .01) and mortality rates (17.5 versus. 8.8%, P = .03) were greater in PJI + SIRS. Risk factors included deficiency anemia (P = .001), blood loss anemia (P = .013), uncomplicated diabetes (P = .006), diabetes with complication (P = .001), electrolyte disorder (P < .00001), neurological disorder (P = .0001), paralysis (P = .026), renal failure (P = .005), and peptic ulcer disease (P = .004). Staphylococcus aureus more commonly speciated on tissue cultures in PJI + SIRS (P = .002). CONCLUSION: The incidence of SIRS is 10% among patients who have PJI. Development of PJI + SIRS is associated with increased lengths of stay, ICU admissions, and 2-year reoperation and mortality rates. Identifying certain comorbidities can stratify patients' risk of developing PJI + SIRS.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. McConnell ZA, Patel KM, Mears SC, et al. Systemic Inflammatory Response Syndrome and Prosthetic Joint Infection. J Arthroplasty. 2023. PMID: 37531981. doi:10.1016/j.arth.2023.07.018

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。